Sign in
Potential Safety Concerns of Bevacizumab
Robert L. Avery, MD
Updates from the Field
2017
Evaluation of Treatment of High Risk Proliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection (ELYSIAN)
Victor Hugo Gonzalez, MD
On Demand Cases, Courses, and Papers
2018
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019
Category: Practice Management